20
Granules India Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for World-class facilities for APIs, PFIs & FDFs, Serving customers in over 75+ countries.
One of their significant offerings is Gliclazide, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2017-240 - Rev 01
This Chemical Type CEP, issued on January 03, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1524 associated with this CEP further emphasizes